MedPath

Effects of Light on Melatonin and Contractions in Pregnant Women

Not Applicable
Completed
Conditions
Pregnancy
Interventions
Device: Lighting2
Device: Lighting1
Registration Number
NCT01863446
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

Specific Aim: Test the hypothesis that ocular light exposure will suppress melatonin secretion and reduce uterine contractions in women at late term pregnancies.

Secondary aim. Test the hypothesis that ocular light exposure will reduce self-reported uterine contractions in women at late term pregnancies.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
51
Inclusion Criteria
  • pregnant at 35-40 weeks
  • first pregnancy
Exclusion Criteria
  • pregnancy-related complications
  • twin or higher pregnancy
  • using medication that affects the sympathetic nervous system

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lighting2Lighting2Ocular light exposure of a blue-green wavelength light for one night
Lighting4Lighting1Ocular light exposure to a red wavelength light on night 1 and to a blue-green wavelength light on night 2
Lighting1Lighting1Ocular light exposure of a red wavelength light for one night
Lighting3Lighting1Ocular light exposure to a red wavelength light on night 1 and to a red wavelength light on night 2
Lighting4Lighting2Ocular light exposure to a red wavelength light on night 1 and to a blue-green wavelength light on night 2
Primary Outcome Measures
NameTimeMethod
Melatonin Area Under the Curve (AUC)4 hours of light exposure.

Melatonin will be assessed using concentrations in saliva or blood. AUC will be calculated using melatonin concentrations during the Outcome Measure Time Frame.

(1) for Lighting1 and Lighting2, the AUC for night 1; (2) for Lighting3 and Lighting4, the AUC for Night 2

Secondary Outcome Measures
NameTimeMethod
Uterine Contractions4 hours of light exposure

Uterine contractions will be measured using a uterine tocometer device

(1) for Lighting1 and Lighting2, the sum for night 1; (2) for Lighting3 and Lighting4, the sum for Night 2

Trial Locations

Locations (1)

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath